GlucoModicum, developers of a non-invasive method for measuring blood glucose, are touting new data that show glucose measurements taken with the company’s non-invasive magnetohydrodynamic (MHD) sampling technology correlate with capillary blood glucose samples.
The results show a mean absolute relative difference – the difference between the measured and the real value – of 12.9%.
This value puts the technology within 10-15% of readings produced by current in-use continuous glucose monitors, like Dexcom’s G7 or Abbott’s FreeStyle Libre 3.